Scottish biotech Trogenix has announced two senior appointments as the company advances its pipeline towards the clinic.

US biotech TRIO Pharmaceuticals has announced the appointment of Patrick Doyle as chief executive (CEO effective immediately.

The market for selective estrogen receptor modulators, or SERMs, is poised for considerable growth over the next decade, ...

The European Medicines Agency has called for updated rules and processes to reflect growing use of artificial intelligence in ...

The Institute for Clinical and Economic Review (ICER) has cast doubt on the value of a new spinal muscular atrophy treatment ...

US precision immune-oncology firm I-Mab has entered into a definitive agreement to acquire 100% ownership of Bridge Health ...

Japanese drug major Astellas Pharma has signed a memorandum of understanding with the Korea Institute of Startup and ...

Behind the Numbers 2026 report, outlining the primary inflators and deflators of healthcare costs across the industry. It ...

A panel of health experts has called on the US regulator to remove boxed warnings from vaginal estrogen treatments, arguing the safety notice is no longer backed by current evidence and discourages ...

Once seen as a niche tool for rare tumors, theranostics is quickly becoming a new standard in cancer care. Combining diagnostics and therapy in a single platform, the field has drawn billions in ...

A major collaboration between the Allen Institute and the Aligning Science Across Parkinson’s (ASAP) initiative is set to ...

The US Food and Drug Administration (FDA) announced the approval of 127 innovator and biosimilar drugs in 2024, a notable ...